The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
ACS Nano · 22.08.2023 · 17 (16) · 15231-15253
DOI: 10.1021/acsnano.2c12584 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Nano, online erschienen am 03.08.2023. Verfasst von Zhongfeng Ye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 258 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States.
- Department of Medical Oncology, Dana-Farber Cancer Institute at Harvard Medical School, Boston, Massachusetts 02215, United States.
- Department of Pharmacology, State University of New York Upstate Medical University, Syracuse, New York 13210, United States.
ORCID-Profile: Qiaobing Xu
Zitieren
APA
Ye, Z., Harmon, J., Ni, W., Li, Y., Wich, D., & Xu, Q. (2023). The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology. ACS Nano, 17(16), 15231-15253. https://doi.org/10.1021/acsnano.2c12584
Vancouver
Ye Z, Harmon J, Ni W, Li Y, Wich D, Xu Q. The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology. ACS Nano. 2023;17(16):15231-15253. doi:10.1021/acsnano.2c12584
BibTeX
@article{Ye2023,
author = {Ye, Zhongfeng and Harmon, Joseph and Ni, Wei and Li, Yamin and Wich, Douglas and Xu, Qiaobing},
title = {The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology},
journal = {ACS Nano},
year = {2023},
volume = {17},
number = {16},
pages = {15231--15253},
doi = {10.1021/acsnano.2c12584}
}
EUVIMED